Krishna Institute of Medical Sciences Limited
Simbols: KIMS.BO
BSE
1965.3
INRTirgus cena šodien
47.3931
P/E koeficients
2.1584
PEG koeficients
157.28B
MRK Cap
- 0.00%
DIV ienesīgums
Krishna Institute of Medical Sciences Limited (KIMS-BO) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1706.5 | 1899.9 | 2842.5 | ||||||||
balance-sheet.row.short-term-investments | 0 | 1090.4 | 1643.5 | 2321.2 | ||||||||
balance-sheet.row.net-receivables | 0 | 2718.9 | 1479.4 | 1373.8 | ||||||||
balance-sheet.row.inventory | 0 | 428.6 | 364.3 | 240.8 | ||||||||
balance-sheet.row.other-current-assets | 0 | 114.7 | 101.7 | 27.3 | ||||||||
balance-sheet.row.total-current-assets | 0 | 4776.4 | 3934 | 4511.9 | ||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 18575.1 | 9094.3 | 8308 | ||||||||
balance-sheet.row.goodwill | 0 | 3080.1 | 847.8 | 847.8 | ||||||||
balance-sheet.row.intangible-assets | 0 | 777.4 | 317.6 | 247.4 | ||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 3857.4 | 1165.3 | 1095.2 | ||||||||
balance-sheet.row.long-term-investments | 0 | 61.7 | 3338.1 | 192.2 | ||||||||
balance-sheet.row.tax-assets | 0 | 401.9 | 32.1 | 29.4 | ||||||||
balance-sheet.row.other-non-current-assets | 0 | 1740.5 | 1509.6 | 224.8 | ||||||||
balance-sheet.row.total-non-current-assets | 0 | 24636.7 | 15139.5 | 9849.6 | ||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-assets | 0 | 29413 | 19073.5 | 14361.5 | ||||||||
balance-sheet.row.account-payables | 0 | 1742.5 | 1295.3 | 1318.7 | ||||||||
balance-sheet.row.short-term-debt | 0 | 445.8 | 302.1 | 884.3 | ||||||||
balance-sheet.row.tax-payables | 0 | 0 | 1.7 | 87 | ||||||||
balance-sheet.row.long-term-debt-total | 0 | 6335.9 | 2263.2 | 2279.4 | ||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 12.4 | ||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||
balance-sheet.row.other-current-liab | 0 | 606.7 | 417.5 | 442.1 | ||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 7068.7 | 2817 | 2816.3 | ||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.capital-lease-obligations | 0 | 1449.6 | 955 | 459 | ||||||||
balance-sheet.row.total-liab | 0 | 10033.4 | 4967.1 | 5599.6 | ||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.common-stock | 0 | 800.3 | 800.3 | 775.9 | ||||||||
balance-sheet.row.retained-earnings | 0 | 5382.8 | 2674.8 | -644.3 | ||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 11140.6 | 11140.6 | 9224 | ||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -628.4 | -742.6 | -718.3 | ||||||||
balance-sheet.row.total-stockholders-equity | 0 | 16695.4 | 13873.1 | 8637.3 | ||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 29413 | 19073.5 | 14361.5 | ||||||||
balance-sheet.row.minority-interest | 0 | 2684.2 | 233.3 | 124.6 | ||||||||
balance-sheet.row.total-equity | 0 | 19379.6 | 14106.4 | 8762 | ||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||
Total Investments | 0 | 566.9 | 3331.7 | 24.3 | ||||||||
balance-sheet.row.total-debt | 0 | 6781.7 | 2565.3 | 3163.7 | ||||||||
balance-sheet.row.net-debt | 0 | 6165.6 | 2308.9 | 2642.4 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 4849.1 | 4568.5 | 2790.2 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1292.6 | 726.7 | 695.4 | ||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.change-in-working-capital | 0 | -692.8 | -744.7 | 141.5 | ||||||||
cash-flows.row.account-receivables | 0 | -628.1 | -232.7 | 177.5 | ||||||||
cash-flows.row.inventory | 0 | 64.7 | -123.4 | 62.9 | ||||||||
cash-flows.row.account-payables | 0 | -410.8 | 101.2 | 239.2 | ||||||||
cash-flows.row.other-working-capital | 0 | 281.4 | -489.7 | -338.1 | ||||||||
cash-flows.row.other-non-cash-items | 0 | -1128 | -1310.3 | -67.3 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -5745.3 | -1703.2 | -944.3 | ||||||||
cash-flows.row.acquisitions-net | 0 | -2161.9 | -3240.9 | -352.7 | ||||||||
cash-flows.row.purchases-of-investments | 0 | -5392.8 | -5828.1 | -2409.6 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 7010.4 | 6520 | 113.8 | ||||||||
cash-flows.row.other-investing-activites | 0 | 133.6 | 137 | 51 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -6155.9 | -4115.2 | -3541.8 | ||||||||
cash-flows.row.debt-repayment | 0 | -2410.8 | -2334.4 | -1300.4 | ||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 1916.6 | 950.2 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-financing-activites | 0 | 3294.2 | 1027.8 | 448.4 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 883.4 | 610 | 98.2 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1311.4 | 0 | 0 | ||||||||
cash-flows.row.net-change-in-cash | 0 | 359.8 | -264.9 | 116.2 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 616.1 | 256.3 | 521.3 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 256.3 | 521.3 | 405.1 | ||||||||
cash-flows.row.operating-cash-flow | 0 | 4320.9 | 3240.3 | 3559.7 | ||||||||
cash-flows.row.capital-expenditure | 0 | -5745.3 | -1703.2 | -944.3 | ||||||||
cash-flows.row.free-cash-flow | 0 | -1424.3 | 1537 | 2615.5 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 21976.8 | 16508.3 | 13122.1 | ||||||||
income-statement-row.row.cost-of-revenue | 0 | 8270.8 | 6170.6 | 4931.1 | ||||||||
income-statement-row.row.gross-profit | 0 | 13706 | 10337.6 | 8191 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0 | 258.7 | 202.6 | 36.1 | ||||||||
income-statement-row.row.operating-expenses | 0 | 8958.4 | 5906.5 | 5063.8 | ||||||||
income-statement-row.row.cost-and-expenses | 0 | 17229.3 | 12077.1 | 9995 | ||||||||
income-statement-row.row.interest-income | 0 | 61.1 | 122.8 | 58 | ||||||||
income-statement-row.row.interest-expense | 0 | 305.4 | 160.3 | 293.1 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -99.5 | -198.2 | -381.9 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0 | 258.7 | 202.6 | 36.1 | ||||||||
income-statement-row.row.total-operating-expenses | 0 | -99.5 | -198.2 | -381.9 | ||||||||
income-statement-row.row.interest-expense | 0 | 305.4 | 160.3 | 293.1 | ||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1292.6 | 726.7 | 695.4 | ||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||
income-statement-row.row.operating-income | 0 | 4887.5 | 4558.7 | 3134 | ||||||||
income-statement-row.row.income-before-tax | 0 | 4849.1 | 4568.5 | 2790.2 | ||||||||
income-statement-row.row.income-tax-expense | 0 | 1190.9 | 1130.6 | 735.4 | ||||||||
income-statement-row.row.net-income | 0 | 3363.2 | 3326.8 | 2012.2 |
Biežāk uzdotie jautājumi
Kas ir Krishna Institute of Medical Sciences Limited (KIMS.BO) kopējie aktīvi?
Krishna Institute of Medical Sciences Limited (KIMS.BO) kopējie aktīvi ir 29413030000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.621.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 42.228.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.138.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.209.
Kāda ir Krishna Institute of Medical Sciences Limited (KIMS.BO) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 3363220000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 6781740000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 8958440000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.